The affinity of integrin-ligand interaction is regulated extracellularly by divalent cations and intracellularly by inside-out signaling. We report here that the extracellular, membraneproximal / stalk interactions regulate not only cation-induced integrin activation, but also play critical roles in propagating the inside-out signaling. Two closely related integrins, IIb 3 and V 3, share high structural homology, bind to similar ligands in an RGD-dependent manner. Despite these structural and functional similarities, they exhibit distinct response to Mn2+. Although V 3 showed robust ligand binding in the presence of Mn2+, IIb 3 showed limited increase but failed to achieve full activation. Swapping stalk regions between IIb and V revealed that the stalk, but not the ligand-binding head region was responsible for the difference. A series of IIb/ V domain-swapping chimeras were constructed to identify the responsible domain. Surprisingly, the minimum component required to render IIb 3 susceptible to Mn2+ activation was the V calf-2 domain that does not contain any divalent cation binding sites. The calf-2 domain makes interface with EGF4 and tail domain ( TD) in 3-dimensional structure. The effect of calf-2 domain swapping was partially reproduced by mutating the specific amino acid residues in the calf-2/EGF4-TD interface. When this interface was constrained by an artificially introduced disulfide bridge, the Mn2+-induced V 3-fibrinogen interaction was significantly impaired. Notably, similar disulfide bridge completely abrogated fibrinogen binding to IIb 3, when IIb 3 was activated by cytoplasmic tail truncation to mimic inside-out signaling. Thus, disruption/formation of the membrane-proximal / stalk interface may act as an on/off switch that triggers integrin-mediated bidirectional signaling.
Integrins are a family of / heterodimeric transmembrane cell surface receptors that mediate cell-extracellular matrix and cell-cell interactions. The hallmark of integrin-dependent adhesive interaction is its regulation by intracellular signaling events (inside-out signaling) and by divalent cations. In addition to mediating adhesive interactions, liganded integrins initiate signals inside the cell to modify cell behavior (outside-in signaling), thus play fundamental roles in numerous biological processes such as differentiation, cell survival, apoptosis, and cell motility (1) . The integrin-mediated bidirectional signaling is accompanied by the conformational change of the integrin structure. The crystal structure of V 3 extracellular domains revealed an unexpected bent conformer distinct from the extended conformer observed under electron microscope (2, 3) . High-resolution electron microscopic observation on truncated recombinant V 3 has confirmed the presence of both conformers, suggesting the transition from one conformer to another might take place under physiological conditions (4) . However, integrin extension per se is not required for the activation but the swing-out of the hybrid domain (transition from "closed" headpiece to "open" headpiece) that accompanies the extension is the critical event (5) . Thus, integrin extracellular domains undergo extensive structural rearrangement (so called "switchblade-like" movement) upon Mn2+/ligand binding. In support, fluorescence resonance energy transfer measurements between 4 1-bound peptide ligand and plasma membrane revealed that such movement actually takes place in living cells (6, 7) . Divalent cations differentially regulate integrin-ligand interaction. While Mn2+, to a lesser extent Mg2+ has an enhancing effect, Ca2+ typically has an inhibitory effect on ligand binding. Biochemical studies have suggested the existence of three classes of cation-binding sites with distinct function and preference for cations (8) . The V 3 extracellular domains turned out to contain eight cation-binding sites. Five of them are located in the -propeller and at the junction between the thigh and the calf-1 domains of the subunit. The other three are located in the A domain of the subunit. Besides the metal ion-dependent adhesion site (MIDAS), which is essential for ligand binding (9, 10) , the A domain possesses two additional sites designated as ADMIDAS (adjacent to MIDAS) and LIMBS (ligand-associated metal binding site), respectively (11) . While ADMIDAS is occupied by a cation regardless of the presence of bound ligand, MIDAS and LIMBS have been shown to bind Mn2+ only in the presence of bound ligand (3, 11) . Recent report by Chen et al suggest that the ADMIDAS is the negative regulatory site, while the LIMBS is the positive regulatory site for Ca2+ (12) . These reports implicate that the cation-binding sites in the A domain represent the three classes of cation-binding sites described by Mould et al (8) , thus they are primarily responsible for the integrin affinity regulation by divalent cations. On the contrary, the role of subunit, particularly the five cation-binding sites, has not been clearly defined.
Two 3 integrins, IIb 3 and V 3 share high structural homology (13) . Both integrins share common 3 subunit and bind fibrinogen (Fbg) 1 , von Willebrand factor, fibronectin, vitronectin in an RGD-dependent manner. Despite these structural and functional similarities, divalent cations regulate ligand binding differently in these integrins. Kinetic studies have shown that Mn2+ supports Fbg binding to both IIb 3 and V 3, albeit with a relatively slow association rate, while Ca2+ supports Fbg binding only to IIb 3 but not to V 3 (14) . In agreement, real-time measurements of Fbg binding interaction have shown that Mn2+ increased the affinity for Fbg in both integrins by increasing the association rate (4, 15) . Consistent with these observations, V 3-mediated cell attachment to immobilized Fbg was greatly enhanced by Mn2+ but not by Ca2+ (14) . By contrast, intact IIb 3 expressed on the cell surface exhibits different characteristics. First of all, cations including Mn2+ are unable to initiate platelet aggregation or to induce Fbg binding to platelets, unless platelets are stimulated by agonists. The agonist-stimulated platelet aggregation is poorly supported by Mn2+, either (14, 16, 17) . These lines of evidence suggest that the cation-binding sites in the A domain do not account for the distinct response to Mn2+ in 3 integrins, but rather the structural difference in the subunit may be responsible. In this study, we sought to determine the mechanism that regulates Mn2+-induced activation in 3 integrins. We provide evidence that the calf-2 domain, but not the cation-binding sites in the subunit plays a critical role in regulating the Mn2+-induced integrin activation. Furthermore, the results suggest that disruption/formation of the membrane-proximal calf-2/EGF4-TD interface may act as an on/off switch that propagates the conformational signals in integrin-mediated bidirectional signaling.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents-Anti-IIb monoclonal antibody (mAb) PL98DF6 (18) was a generous gift from Drs. J. Ylänne (University of Upsala, Finland) and I. Virtanen (University of Helsinki, Finland). Conformation-dependent anti-3 mAbs, anti-LIBS1 and anti-LIBS2 (19) were generous gifts from Dr. Mark H. Ginsberg (University of California, San Diego). Anti-IIb 3 complex-specific ligand-mimetic mAb OP-G2 (20) was a kind gift from Dr. Yoshiaki Tomiyama (University of Osaka, Japan). The IIb 3 complex specific anti-IIb mAb P2, anti-3 mAb SZ21, and anti-V mAb AMF-7 were purchased from Beckman Coulter (Fullerton, CA). Anti-IIb 3 complex-specific activating mAb PT25-2 and non-functional anti-3 mAb VNR5-2 has been previously characterized (21) . FITC-and RPE-conjugated goat anti-mouse polyclonal antibodies were purchased from Biosource (Camarillo, CA Fibrinogen Binding Assay-FITC-labeling of human Fbg was performed as previously described (22) . Briefly, after adjusting the pH of human Fbg at 1 mg/ml in PBS to 8.5 with 5% Na2CO3, 1/100 volume of 10 mg/ml FITC in DMSO was added and incubated at room temperature for 10 min.
FITC-labeled Fbg was separated from free FITC on PD-10 column (Amersham Biosciences, Uppsala, Sweden) equilibrated with HEPES-buffered saline. The concentration and F/P ratio of FITC-labeled Fbg was calculated as previously described. Forty-eight hours after transfection, cells were detached and incubated with non-functional anti-3 mAb VNR5-2 followed by RPE-conjugated F(ab')2 fragment of goat anti-mouse IgG. In some experiments, cells were treated with 10 mM dithiothreitol (DTT) prior to incubating with mAbs as described previously (21) . After washing, cells were incubated with FITC-labeled Fbg at 200 μg/ml with or without 1mM GRGDS peptide in modified HEPES-Tyrode buffer containing 1 mM CaCl2 and 1 mM MgCl2 or 1 mM MnCl2 for 1 hour at 4˚C. In some experiments, mAb PT25-2 was included at 10 μg/ml to activate IIb 3. After washing, fluorescence was measured on FACSCalibur. The mean Fbg binding (FL1) to cell populations expressing high 3 (FL2>500) was calculated. Background binding in the presence of 1 mM GRGDS peptide was subtracted to obtain specific binding.
RESULTS

Swapping Stalk Region Switches the Enhancing Effect of Mn2+ on Ligand
Binding-To locate the structure in the subunit responsible for the difference in Mn2+-activation, we first swapped the C-terminal stalk region consisting of thigh, calf-1, calf-2, transmembrane (TM), and cytoplasmic (Cyto) domains between IIb and V. The B/V chimera has IIb -propeller joined with V stalk, while the V/B chimera has V propeller joined with IIb stalk. In terms of cation-binding site, only the site at the junction between the thigh and the calf-1 domains is replaced in those chimeras and the other four sites in the -propeller domain remain unchanged (Fig. 1A) . The chimeras were transiently expressed in CHO cells. Surface expression of each chimeric molecule was monitored using mAbs, PL98DF6, P2, SZ21, PT25-2, OP-G2, and AMF-7. All chimeras showed comparable mAb binding as wild-type IIb 3 or V 3 (data not shown). In the presence of 1 mM Ca2+/Mg2+ without any activators, none of the cells expressing chimeras including wild-type IIb 3 or V 3 significantly bound Fbg (Fig. 1B) . In the presence of mAb PT25-2 that binds to IIb -propeller and activates IIb 3 (21-23), Fbg bound to wild-type IIb 3 and to B/V chimera, but not to wild-type V 3 or to V/B chimera. This is because this particular antibody is unable to bind to V 3 or to V/B. In the presence of 1mM Mn2+, although IIb 3 did show some binding, it was not as avid as in the presence of PT25-2. By contrast, Mn2+ induced robust Fbg binding to wild-type V 3. These results are in agreement with previous reports. However, when stalk was swapped, the response to Mn2+ changed completely from the wild-type. The B/V bound Fbg just as avidly as wild-type V 3. By contrast, the V/B's binding significantly decreased to the similar level as wild-type IIb 3. These results clearly indicate that the integrin stalk, but not the head, contains critical component that regulates Mn2+-induced integrin activation. The V Calf-2 Domain, Not the IIb Calf-2 Domain Facilitates Mn2+-induced Activation-To locate the regulatory domain essential for Mn2+-induced activation, we created 9 additional domain-swapping chimeras (Fig. 1A) . These chimeras were created based on the domain boundaries in the V 3 crystal structure (3). All of them have IIb -propeller on the N-terminus. Thus, the ligand-binding domains remain unchanged. Each chimera was designated after the domain replaced except for the D chimera that has V TM and Cyto domains. The chimeras were transiently expressed in CHO cells. Surface expression of each chimera was comparable (data not shown). The first set of experiments showed that TC1C2 bound Fbg just as avidly as B/V in the presence of Mn2+ (Fig. 1C) . However, Mn2+ did not induce Fbg binding in TC1 or T. When the cells were pretreated with DTT, which is known to activate integrin, all chimeras including TC1 and T showed comparable Fbg binding as wild-type IIb 3 in the presence of 1mM Ca2+/Mg2+. These results suggest that the V calf-2 domain is required for Mn2+-induced activation but not the V TM or Cyto domains. It is worth to note that none of the chimeras induced constitutive activation. To confirm if V calf-2 domain alone can facilitate IIb 3-Fbg interaction by Mn2+, we swapped individual domains in the next set of experiments. Although swapping individual thigh (T), calf-1 (C1), TM-Cyto (D) domains had no effect, swapping calf-2 domain (C2) resulted in robust Fbg binding in the presence of Mn2+ (Fig.  1D) . These results suggest that the V calf-2 domain has a facilitating effect on ligand binding by Mn2+, while the IIb calf-2 domain lack the same effect. To examine if IIb calf-2 domain alone can neutralize the activating effect of stalk swapping, individual IIb domain sequences were put back in the B/V chimera that shows Mn2+-induced activation. When original IIb thigh (C1C2D), calf-1 (TC2D), TM-Cyto (TC1C2) domain sequences were put back in, they did not have significant effect on Mn2+-induced activation induced by stalk swapping. However, when IIb calf-2 domain sequences were put back in (TC1D), the Mn2+-induced activation was completely lost (Fig. 1E ). This suppressing effect was reversed by DTT treatment. These results suggest that the differences in the response to Mn2+ between IIb 3 and V 3 can be solely attributed to the calf-2 domain.
Mutation in the Cation-Binding Site at Genu Does Not Affect Mn2+-induced Ligand Binding-
In the V 3 crystal structure, the only cation-binding site in the stalk is located at the junction between the thigh and the calf-1 domains, but not in the calf-2 domain. To examine the effect of this cation-binding site on ligand binding, Asp-599 and Glu-636 that coordinate a cation at V genu were mutated to Ala. These two acidic residues are conserved in most integrins. Mutating individual amino acid residues to Ala did not inhibit V 3-Fbg interaction induced by Mn2+ (Fig. 2) . It did not induce constitutive activation in the presence of 1 mM Ca2+/Mg2+, either. Although these results do not rule out the possibility that this cation-binding site may play some role in ligand binding, they are consistent with the results obtained using domain-swapping chimeras.
Specific Amino Acid Residues at the Calf-2/ EGF4-TD Interface Regulates Mn2+-induced
Ligand Binding-In the V 3 crystal structure, the calf-2 domain creates a 700 Å interface with EGF4 and TD (24) . This implicates that the difference in the interaction between those membrane-proximal domains might affect Mn2+-dependent integrin activation. To explore this possibility, we mutated amino acid residues in the IIb calf-2 domain that make up the interface. (Fig. 3D) . These results indicate that the effect of calf-2 domain swapping on Mn2+-induced ligand interaction is mediated at least in part by the specific amino acid residues in the calf-2/EGF4-TD interface, suggesting that the differences in the calf-2/EGF4 and calf-2/ TD interface interaction in two 3 integrins are indeed responsible for the distinct response to Mn2+. However, the fact that combining B/V 760-764, B/V 787, and B/V 899-900 mutations did not produce as much Fbg binding as C2 indicates that other amino acid residues in the calf-2 domain are involved. The positions of amino acid residues 839-867 in the V calf-2 domain (842-873 in IIb) have not been assigned in the V 3 crystal structure. This region may provide additional sites important for regulating integrin-ligand interaction.
Constraining the Calf-2/EGF4-TD Interface in
V 3 Inhibits Mn2+-induced Activation-If calf-2/EGF4-TD interface interaction is involved in the regulation of Mn2+-induced ligand binding, constraint in the interface should have an profound impact on integrin activation and conformation. To examine this hypothesis, we introduced an artificial disulfide bridge to put constraint in this interface. As seen in Fig. 4A , V Ser-749 and 3 Asp-606 are physically close and if these residues were mutated to Cys at the same time, we will be able to introduce a disulfide bridge. Although individual V S749C or 3 D606C did not have any significant effect, double cysteine mutation 749/606 reduced Fbg binding to about one-third (Fig. 4B ). This suppression was neutralized when the cells were treated with DTT to disrupt the disulfide bridge. These results suggest that restraining the possible movements in this membrane-proximal domain interface has significant inhibitory effect on Mn2+-induced integrin activation.
Next we examined the effect of the constraint on the conformational change of V 3. To monitor the conformational change, we examined the binding of anti-LIBS antibodies. The anti-LIBS mAbs bind preferentially to ligand-occupied form of integrins. Thus they are believed to detect conformational changes associated with ligand binding (19) . In this assay, the binding of non-functional anti-3 mAb VNR5-2 did not change among those mutants. The presence of 1 mM GRGDS peptide did not significantly affect the binding, either (Fig. 4C) . The binding of anti-LIBS1 was significantly weaker than VNR5-2. However, it showed robust increase in the presence of 1 mM GRGDS peptide. No significant difference was observed among wild-type and cysteine mutants (Fig. 4D) . By contrast, anti-LIBS2 binding in the presence of GRGDS peptide was suppressed in the double mutant (Fig. 4E) . Although the localization of the epitope for anti-LIBS1 has not been known, the epitope for anti-LIBS2 has been located within amino acid residues 602-690 in the TD (25) . These results suggest that the constraint on the membrane-proximal / interface restricts the conformational change within the membrane-proximal domain upon ligand binding. However, it may not prevent the conformational change in other parts of the molecule.
Constraint in the Calf-2/EGF4-TD Interface in IIb 3
Completely Abrogates Inside-Out Signaling-We next examined the effect of this interdomain interaction on integrin activation induced by other stimuli. We introduced homologous cysteine mutation into IIb 3 and examined the effect on Fbg binding in the presence of 1 mM Ca2+/Mg2+ (Fig. 5A) . Without activators, none of those mutants bound Fbg. When activating mAb PT25-2 was included to enforce the conformational change of the extracellular domain in favor of ligand binding, wild-type ( IIb/ 3) and individual cysteine mutants IIb F755C (755/ 3) and 3 D606C ( IIb/606) showed comparable Fbg binding. However, the Fbg binding to double cysteine mutant 755/606 showed 50% decrease. The effect of the constraint was neutralized when the disulfide bridge was disrupted by prior treatment with DTT. These results suggest that constraining the membrane-proximal domain interface prevent integrin from achieving full activation regardless of activators.
The effect of the constraint is far more dramatic in inside-out signaling. To mimic inside-out signaling, the Cyto domain of 3 was truncated at the membrane-proximal Leu-717 (26) . The truncated IIb 3 ( IIb/ 3tr) bound Fbg in the presence of Ca2+/Mg2+ without any activators, as reported previously (Fig. 5B) . When individual cysteine mutation IIb F755C or 3 D606C was introduced in truncated IIb 3 (designated as 755/ 3tr, IIb/606tr, respectively), it did not significantly block Fbg binding. By contrast, Fbg binding was completely abrogated in double cysteine mutant 755/606tr. Activating antibody did not override the inhibition completely. Fbg binding was completely restored only when the disulfide bridge was disrupted with DTT treatment. The cysteine mutations had similar effects when IIb 3 was activated by IIb Cyto domain truncation (Fig. 5C ). Although individual IIb F755C or 3 D606C mutation (775tr/ 3, IIbtr/606, respectively) did not have significant impact as compared with wild-type ( IIbtr/ 3), double cysteine mutation 755tr/606 completely abrogated Fbg binding. This suppression was completely neutralized with DTT treatment. Thus, disruption of the membrane-proximal domain interface is essential for propagating the inside-out signaling. These results suggest that constraining the membrane-proximal / interface not only restricts integrin activation by divalent cations, but also prevents activation by inside-out signaling.
DISCUSSION
In this study, we provide evidence that interdomain interactions in the integrin stalk regions, particularly in the membrane-proximal domains, is the key regulator of integrin activation. By using Mn2+-induced Fbg binding to 3 integrins as a model system, we demonstrated 1) that switching stalk region resulted in switching the Mn2+ requirement for ligand binding in IIb 3 and V 3, 2) that the calf-2 domain in stalk region is the sole determinant for the distinct response to Mn2+, 3) that this response is mediated in part by the specific amino acid residues in the calf-2 domain that creates the calf-2/EGF4-TD interface, 4) that constraining the calf-2/EGF4-TD interface not only inhibited Mn2+-induced integrin activation, but completely abrogated inside-out signaling. These results suggest that the extracellular, membrane-proximal / interaction not only play important roles in regulating the cation-dependent integrin activation, but critically controls the propagation of inside-out signaling.
Integrin subunit contains five cation-binding sites. The four EF-hand-like motifs in subunit previously predicted to bind Ca2+ form hairpin loops and actually coordinate cations regardless of bound ligand (3). Although previous studies have shown that the Fbg -chain peptide cross links to the second EF-hand-like motif in the blade 5 of IIb propeller (27) , mutational studies suggest these sites are not likely to contain a major ligand-binding site (28, 29) . In addition, conservative Asp/Asn to Glu mutations in the four EF-hand-like motifs in 4 1 had no effect on the binding of soluble ligand (30) . Consistently, these hairpin loops are all located opposite to the -propeller/ A interface that comprise the ligand binding face. Our results using stalk-swapping mutants suggest that the -propeller domain does not contain a regulatory site for Mn2+-induced Fbg binding, but the stalk does. Indeed, the stalk contains the fifth cation-binding site at the junction between the thigh and the calf-1 domains. This site is located at the genu where integrin makes a 135-degree bend in the crystal structure. It has been predicted that a cation bound to this site may help neutralize the negative charge in the thigh/calf-1 interface in an extended conformer (3). Thus, it is tempting to speculate that this cation-binding site may regulate Mn2+-induced ligand binding by controlling the transition from bent to extended conformer. However, our results suggest this is not the case. Instead, results from the domain-swapping chimeras indicate that the C-terminal calf-2 domain plays a critical role in regulating integrin activation.
Several lines of evidence implicate the role of the calf-2 domain in integrin activation. Some integrin subunit is proteolytically cleaved into covalently linked heavy and light chains during post-translational processing. Prevention of this endoproteolytic cleavage by mutagenesis abrogated 6 1 activation by PMA (31). Neutrophil elastase cleaves IIb between Val-837 and Asp-838 close to the endoproteolytic cleavage site in the calf-2 domain (32) . Although the elastase does not by itself induce platelet aggregation, it greatly potentiates IIb 3 activation by cathepsin G and by Mn2+ (17,33) . Thus, structural alterations in the calf-2 domain affect integrin activation. Conversely, ligand binding provokes structural change in the calf-2 domain. Upon ligand binding, the integrin stalk regions express neoepitopes that is recognized by a group of anti-LIBS mAbs. These epitopes are mostly located in the stalk region (25, 34) . Notably, one such mAb PMI-1 recognizes an epitope within 842-856 of the IIb calf-2 domain (35) . Thus, structural change in the calf-2 domain is closely associated with integrin activation. How does calf-2 domain affect Mn2+-induced Fbg binding despite it does not contain actual cation-binding sites? Previous studies suggest that the membrane-proximal / interaction modulate integrin affinity regulation by divalent cations. Kinetic studies using recombinant truncated 5 1 and V 3 with an artificial C-terminal clasp suggest that / interaction in the TM and the Cyto domains decrease integrin affinity by increasing the dissociation rate. Electron microscopic observation revealed that the two stalks are widely separated at their ends in unclasped 5 1 (36), while they are still connected at their ends in a majority of molecules in unclasped recombinant V 3 even in the presence of Mn2+ (4). These reports suggest that the extracellular, membrane-proximal / interface formation is significant in some integrins under physiological conditions and may account for the distinct response to Mn2+ in 3 integrins. Indeed, IIb to V mutation in selected amino acid residues that make up the calf-2/EGF4 and the calf-2/ TD interface greatly facilitated Mn2+-induced Fbg binding in IIb 3. Stabilizing this interface with a disulfide bridge (749/606 mutant) prevented Mn2+-induced Fbg binding to V 3. It is possible that constraining the membrane-proximal / interface may somehow constrain integrin in a bent state, thereby keeps integrin in a low affinity state. However, the 749/606 and 755/606 double mutant did undergo conformational change upon ligand binding as detected by LIBS epitope expression and bound Fbg when stimulated by Mn2+ or by activating mAb, albeit attenuated. By contrast, constraining the integrin in a bent state by introducing a disulfide bridge between A and TD resulted in failure to induce LIBS epitope expression upon ligand binding and complete loss of ligand binding even in the presence of activating mAb 2 . Thus, constraining the / stalks and head/ stalk have distinct conformational effect on integrin structure. In addition, the fact that extended, clasped conformer can be observed under electron microscopy (4) indicates that constraining the / stalks does not necessarily constrain integrin in a bent state. On the contrary, disruption of the membrane-proximal / interface may lead to integrin activation. Anti-LIBS2 that binds to TD has been shown to activate IIb 3 (25) . Likewise, two mAbs that bind to IIb calf-2 domain weakly induced Fbg binding in the presence of Ca2+/Mg2+. Notably, these mAbs potentiated Mn2+-induced Fbg binding 3 . Disruption of the Cys608-Cys655 and Cys663-Cys687 disulfide bridges in TD that face the calf-2/EGF4-TD interface in the crystal structure constitutively activated IIb 3, while disruption of the other two disulfide bridges did not (37) . These results implicate that the membrane-proximal calf-2/EGF4-TD interface may act as a physiological clasp, thus regulate integrin activation.
Integrin stalks make interface also at calf-1/EGF3, at TM domains, and at Cyto tails. Previous studies suggest that / interaction in TM domain and Cyto tail as well as the interaction of Cyto tails with actin cytoskeleton is important for restraining integrins in low affinity form (38) (39) (40) (41) . These membrane-proximal interactions probably act in concert to maintain integrin in default low affinity state, since disruption of any of these interactions makes integrin prone to activation. This may explain why the detergent-solubilized or truncated recombinant IIb 3 is able to bind ligands without activation, while intact heterodimers on the platelet surface is not. Among / interfaces, calf-2/EGF4-TD is especially unique, since only calf-2 domain, not thigh, calf-1, or TM-Cyto domains displayed significant difference in promoting Mn2+-induced integrin activation, suggesting this interface is much stable in IIb 3 than in V 3. This divergent nature of the calf-2/EGF4-TD interface interaction among integrins may be responsible for the different LIBS epitope expression in 1 integrins in response to ligand or Mn2+ occupancy (42) . Thus, the calf-2/EGF4-TD interaction may differentially regulate ligand interaction and conformational change in integrins.
In inside-out signaling, how the interactions within the short Cyto tails trigger structural rearrangements in the large extracellular domain remains a mystery. The cytoplasmic, membrane-proximal interaction constrains integrin in an inactive state (40) . Recently, the talin head domain has been shown to activate IIb 3 by disrupting the membrane-proximal IIb/ 3 tail interface in vitro (43) . In living cell, the L/ 2 Cyto tails undergo separation upon agonist stimulation (44) . Conversely, in outside-in signaling, ligand binding induces a structural rearrangement in the Cyto tails and induces separation of the tails (44) and exposure of the LIBS epitope in tail (45) . Our results unequivocally indicate that separation of the Cyto tails is unable to induce integrin activation unless the extracellular stalks separates from each other. In agreement, previous studies has shown that IIb 3 stalks undergo structural rearrangement and change their relative distance or orientation on the cell surface upon agonist stimulation of platelets (46) . Thus, disruption of the calf-2/EGF4-TD interface that follows the / Cyto tail separation triggers a cascade of structural rearrangement of integrin extracellular domains in inside-out signaling. Most likely, disruption of the calf-2/EGF4-TD interface would be required for the propagation of outside-in signaling as well.
Based on the results from the current and previous studies, we propose a relay switch model of integrin activation (Fig. 6) . The stalk makes extensive interfaces not only with stalk, but also with head comprised of A and hybrid domains. These multiple interactions involving the stalk seem to constrain integrin in inactive form, since disruption of virtually any disulfide bridges in the four EGF domains constitutively activate IIb 3 (47) . In this model, the / stalk and the head/stalk interactions are physically linked, functioning as a relay switch to transmit conformational signals from one end to the other: disruption of the / stalk interface destabilizes the head/stalk interface and vice versa. In inside-out signaling (Fig. 6 lower panel) , interaction of integrin Cyto tails with intracellular proteins such as talin disrupts the / Cyto tail and the TM domain interfaces. This triggers the disruption of the / stalk interface that would destabilize the head/stalk interface. Destabilization of the head/stalk interface releases the A-hybrid domains from the constraint that prevents the swing-out of the hybrid domain, thus greatly potentiates integrin activation. However, this may not be sufficient to induce extension, since mAb cross-competition studies implicate that IIb 3 still assumes a bent conformer on agonist-stimulated platelets (48) . Consistently, agonist stimulation alone is not sufficient but requires ligand binding to induce LIBS epitope expression in platelet IIb 3 (19, 49) . Thus, ligand binding and associating swing-out of the hybrid domain may give an additional push to the structural transition. Alternatively, / stalk separation may be able to induce significant integrin extension without swing-out of the hybrid domain (extended, closed headpiece), facilitating the access of macromolecular ligands. In outside-in signaling (Fig. 6 upper panel) , Mn2+ binding to the A domain may be able to induce conformational change in the head sufficient to destabilize the head/stalk interface. This triggers destabilization of the / stalk interface that further makes head/stalk interface unstable, potentiating integrin activation. With increased affinity, the binding of ligands facilitates swing-out of the hybrid domain (50) , which would completely disrupt the head/stalk interface and allow integrin to extend, followed by the complete separation of the / stalk, exposing the binding sites for signaling molecules in the cytoplasmic tails. However, tight interaction in the calf-2/EGF4-TD interface prevents destabilization in the head/stalk interface and keeps integrin in low affinity state in IIb 3. Alternatively, Mn2+ alone may be able to induce integrin extension without releasing the C-terminal clasp (extended, closed headpiece). Ligand binding following Mn2+ occupancy induces swing-out of the hybrid domain that promotes the release of the C-terminal clasp (extended, open headpiece). The extended, closed form may be predominant in 1 and 2 integrins, since Mn2+ alone induces significant LIBS epitope expression (42) . By contrast, Mn2+ does not induce significant LIBS epitope expression in 3 integrins (data not shown). This model explains how structural signals initiated in the C-terminal tail and in the N-terminal ligand-binding head propagate to each other. Our results suggest that any endogenous molecules or reagents that potentially affect / interface formation may modulate integrin activation. Indeed CD151, PDGF receptor , VEGF receptor 2, and CD47 has been shown to associate with integrin extracellular domains (51-54). These molecules may affect integrin activation by interfering or by stabilizing the intersubunit or intrasubunit interface formation by binding to integrin stalks. Likewise, chemicals or reagents that cross-link and stabilize the calf-2/EGF4-TD interface will be able to selectively inhibit inside-out signaling and probably outside-in signaling as well without inhibiting low affinity ligand binding or inducing LIBS epitope expression. Thus, membraneproximal / interaction can be a novel target for effective anti-integrin therapies. 
